John Martin Docherty, President & CSO at Lexaria Bioscience Corp. (LEXX), bought 5,376 shares at $0.93 ($5K) on 2025-07-29, disclosed to the SEC on 2025-07-30.
Open-market purchase of $5k LEXX by President & CSO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| LXRP | BUY | 2015-07-23 | $85K | — | Filing → |
| LXRP | BUY | 2015-05-22 | $13K | — | Filing → |